Nuventra Pharma Sciences Named a TBJ Fast 50 Award Winner for Fourth Consecutive Year
Nuventra Pharma Sciences is pleased to announce that it has been ranked as a part of the Triangle Business Journal’s Fast 50 List honoring the 50 fastest growing privately held…
Read More
Nuventra’s Brian Furmanski to Present at AACP/AAPS Webinar, “Navigating and Understanding FDA Review Documents”
Nuventra’s Brian Furmanski, PhD, will present during the upcoming AACP and AAPS sponsored webinar titled, “Navigating and Understanding FDA Review Documents.” The webinar will take place on Thursday, October 24…
Read More
Nuventra Announces Addition of Devin Welty to its Growing Team of Clinical Pharmacology Experts
Nuventra is pleased to announce the addition of Devin Welty, Ph.D. as Senior Consultant, Nonclinical & Clinical Pharmacology to its growing team of senior consultants. Dr. Welty has over 25…
Read More
Nuventra Ranks on Inc. 5000 List for Sixth Consecutive Year
Inc. Magazine revealed today that Nuventra Pharma Sciences has once again ranked on the Inc. 5000 list for 2019. This marks the sixth year in a row that Nuventra has…
Read More
Nuventra Announces Addition of Chuck Poole and Howard A. Ball to its Growing Team of Clinical Pharmacology Experts
Nuventra is pleased to announce the addition of two experienced scientists, Chuck Poole, B.S. and Howard A. Ball, Ph.D., to its growing team of senior consultants. Both bring more than…
Read More
Nuventra Renovates & Expands Durham Headquarters to Accommodate Growth
Nuventra Pharma Sciences is excited to announce the completion of its newly renovated company headquarters in Durham, NC. The expanded and redesigned 15,000 square foot space features eight conference rooms…
Read More
Nuventra Pharma Sciences to Present and Exhibit at ASCPT Annual Meeting
Nuventra is proud to announce its participation at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting and Exposition on March 13 – 16, 2019 in Washington, D.C. Nuventra will…
Read More